Gladys E Granero
Overview
Explore the profile of Gladys E Granero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scolari I, Paez P, Granero G
Heliyon
. 2024 Feb;
10(3):e25604.
PMID: 38356535
Gentamicin (GEN), a widely used broad-spectrum antibiotic, faces challenges amid the global emergency of antimicrobial resistance. This study aimed to explore the synergistic effects of zinc oxide nanoparticles (ZnO NPs)...
2.
Peralta M, Mendieta S, Scolari I, Gerbaldo M, Oliva M, Gil G, et al.
Heliyon
. 2023 Nov;
9(10):e21030.
PMID: 37916071
Current cancer chemotherapy is associated with many side effects and, in some cases, drug resistance, which makes the search for new active molecules and drug delivery strategies imperative. Carbamazepine is...
3.
Scolari I, Volpini X, Fanani M, de la Cruz-Thea B, Natali L, Musri M, et al.
Mol Pharm
. 2020 Dec;
18(3):807-821.
PMID: 33356316
Nanotechnology is a very promising technological tool to combat health problems associated with the loss of effectiveness of currently used antibiotics. Previously, we developed a formulation consisting of a chitosan...
4.
Scolari I, Paez P, Sanchez-Borzone M, Granero G
AAPS PharmSciTech
. 2019 Jan;
20(2):67.
PMID: 30627867
The aim of this study was to design a nanocarrier system for inhalation delivery of rifampicin (RIF) in combination with ascorbic acid (ASC), namely constituted of sodium alginate coated with...
5.
Quinteros M, Viviana C, Onnainty R, Mary V, Theumer M, Granero G, et al.
Int J Biochem Cell Biol
. 2018 Sep;
104:87-93.
PMID: 30243952
The oxidative stress generation in bacteria by the presence of antibiotics (in this case silver nanoparticles (AgNPs)) is already widely known. Previously, we demonstrated that AgNPs generate oxidative stress in...
6.
Aloisio C, Ponce-Ponte M, Granero G, Longhi M
AAPS PharmSciTech
. 2018 Jun;
19(6):2629-2638.
PMID: 29922876
The aim of this work was to predict the permeability of two model drugs, sulfamerazine (SMR) and indomethacin (INM), and to determine the effect on their apparent permeabilities by complexation...
7.
Real J, Granero G, De Santis M, Juarez C, Palma S, Kelly S, et al.
Graefes Arch Clin Exp Ophthalmol
. 2014 Dec;
253(11):1859-65.
PMID: 25491161
Purpose: To explore decline in visual acuity in patients with neovascular age-related macular degeneration (n-AMD) awaiting intravitreal bevacizumab or ranibizumab treatment following initial diagnosis and after disease reactivation. Methods: Retrospective...
8.
Mora M, Petiti J, Longhi M, Torres A, Granero G
Int J Pharm
. 2014 Dec;
478(1):258-267.
PMID: 25448587
Large oral doses of ACZ lower the intraocular pressure (IOP), but usually lead to a multitude of systemic side effects, including gastrointestinal upset. The present study was undertaken to evaluate...
9.
Mora M, Tartara L, Onnainty R, Palma S, Longhi M, Granero G
Carbohydr Polym
. 2013 Aug;
98(1):380-90.
PMID: 23987358
The effects of binary and ternary systems of acetazolamide (ACZ) with hydroxypropyl-β-cyclodextrin (HP-β-CD) alone or with triethanolamine (TEA) on the crystalline properties, dissolution and intraocular pressure (IOP)-lowering effect were investigated....
10.
Real J, Luna J, Urrets-Zavalia J, De Santis M, Palma S, Granero G
Eur J Ophthalmol
. 2013 May;
23(6):857-64.
PMID: 23661541
Purpose: Ranibizumab and bevacizumab coexist as the main therapeutic strategies for the treatment of neovascular age-related macular degeneration (NV-AMD). In Argentina, the access pathways to the drugs are different. Patients...